Bell's palsy following the Ad26.COV2.S COVID-19 vaccination

被引：16
|
作者：
Nishizawa, Y. [1 ]
Hoshina, Y. [1 ]
Baker, V [1 ]
机构：
[1] US Naval Hosp Yokosuka, Dept Neurol, 82 Inaoka Cho, Yokosuka, Kanagawa 2380001, Japan
来源：
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE | 2021年 / 114卷 / 09期
关键词：
D O I：
10.1093/qjmed/hcab143
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：657 / 658
页数：2
相关论文
共 50 条
  • [21] Oral lichen planus following the administration of vector-based COVID-19 vaccine (Ad26.COV2.S)
    Troeltzsch, Matthias
    Gogl, Markus
    Berndt, Ronald
    Troeltzsch, Markus
    ORAL DISEASES, 2022, 28 : 2595 - 2596
  • [22] Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination
    Geers, Daryl
    Sablerolles, Roos S. G.
    van Baarle, Debbie
    Kootstra, Neeltje A.
    Rietdijk, Wim J. R.
    Schmitz, Katharina S.
    Gommers, Lennert
    Bogers, Susanne
    Nieuwkoop, Nella J.
    van Dijk, Laura L. A.
    van Haren, Eva
    Lafeber, Melvin
    Dalm, Virgil A. S. H.
    Goorhuis, Abraham
    Postma, Douwe F.
    Visser, Leo G.
    Huckriede, Anke L. W.
    Sette, Alessandro
    Grifoni, Alba
    Swart, Rik L. de
    Koopmans, Marion P. G.
    van der Kuy, P. Hugo M.
    GeurtsvanKessel, Corine H.
    de Vries, Rory D.
    ISCIENCE, 2023, 26 (01)
  • [23] Multisystem Inflammatory Syndrome after Ad26.COV2.S vaccination
    Bova, Carlo
    Vigna, Ernesto
    Gentile, Massimo
    IDCASES, 2022, 27
  • [24] Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome
    Li, Hai-Feng
    Hu, Shi-Min
    Lv, Ming
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (04): : 392 - +
  • [25] Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
    Sadoff, Jerald
    Gray, Glenda
    Vandebosch, An
    Cardenas, Vicky
    Shukarev, Georgi
    Grinsztejn, Beatriz
    Goepfert, Paul A.
    Truyers, Carla
    Fennema, Hein
    Spiessens, Bart
    Offergeld, Kim
    Scheper, Gert
    Taylor, Kimberly L.
    Robb, Merlin L.
    Treanor, John
    Barouch, Dan H.
    Stoddard, Jeffrey
    Ryser, Martin F.
    Marovich, Mary A.
    Neuzil, Kathleen M.
    Corey, Lawrence
    Cauwenberghs, Nancy
    Tanner, Tamzin
    Hardt, Karin
    Ruiz-Guinazu, Javier
    Le Gars, Mathieu
    Schuitemaker, Hanneke
    Van Hoof, Johan
    Struyf, Frank
    Douoguih, Macaya
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23): : 2187 - 2201
  • [26] VITT following Ad26.COV2.S vaccination presenting without radiographically demonstrable thrombosis
    Kennedy, Vanessa E.
    Wong, Chelsea C.
    Hong, Jessica M.
    Peng, Theodore
    Brondfield, Sam
    Reilly, Linda M.
    Cornett, Patricia
    Leavitt, Andrew D.
    BLOOD ADVANCES, 2021, 5 (22) : 4662 - 4665
  • [27] Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice
    Shant H. Mahrokhian
    Lisa H. Tostanoski
    Catherine Jacob-Dolan
    Roland C. Zahn
    Frank Wegmann
    Katherine McMahan
    Jingyou Yu
    Makda S. Gebre
    Esther A. Bondzie
    Huahua Wan
    Olivia Powers
    Tianyi Ye
    Julia Barrett
    Hanneke Schuitemaker
    Dan H. Barouch
    npj Vaccines, 7
  • [28] Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector-based COVID-19 vaccine
    Le Gars, Mathieu
    Hendriks, Jenny
    Sadoff, Jerry
    Ryser, Martin
    Struyf, Frank
    Douoguih, Macaya
    Schuitemaker, Hanneke
    IMMUNOLOGICAL REVIEWS, 2022, 310 (01) : 47 - 60
  • [29] Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice
    Mahrokhian, Shant H.
    Tostanoski, Lisa H.
    Jacob-Dolan, Catherine
    Zahn, Roland C.
    Wegmann, Frank
    McMahan, Katherine
    Yu, Jingyou
    Gebre, Makda S.
    Bondzie, Esther A.
    Wan, Huahua
    Powers, Olivia
    Ye, Tianyi
    Barrett, Julia
    Schuitemaker, Hanneke
    Barouch, Dan H.
    NPJ VACCINES, 2022, 7 (01)
  • [30] Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine
    Sadoff, J.
    Le Gars, M.
    Shukarev, G.
    Heerwegh, D.
    Truyers, C.
    de Groot, A. M.
    Stoop, J.
    Tete, S.
    Van Damme, W.
    Leroux-Roels, I
    Berghmans, P-J
    Kimmel, M.
    Van Damme, P.
    de Hoon, J.
    Smith, W.
    Stephenson, K. E.
    De Rosa, S. C.
    Cohen, K. W.
    McElrath, M. J.
    Cormier, E.
    Scheper, G.
    Barouch, D. H.
    Hendriks, J.
    Struyf, F.
    Douoguih, M.
    Van Hoof, J.
    Schuitemaker, H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (19): : 1824 - 1835
12345